Series B

Cardialen jumpstarts $17m series B
The George Washington spinout had previously raised $4.1m in equity for its low-voltage implantable cardiac defibrillator.
Gilmour Space thrusts $13.7m into orbit
Satellite launching rocket producer Gilmour Space Technologies has been backed by Main Sequence Ventures, managers of Csiro Innovation Fund, taking its total to $17.4m.
Morphic shapes $80m series B
Novo has co-led a series B round together with Omega Funds for Morphic Therapeutic, based on research by Harvard professor Timothy Springer.
Immune-Onc books $33m series B
Immune-Onc, an immuno-oncology therapy developer exploiting University of Texas research, has received more than $33m from investors including Stanford-StartX fund.
RSP Systems inspects $12.1m series B
RSP Systems, a spinout of University of Southern Denmark, has extended its series B round to $12.1m following a $4.5m extension backed by Trumpf Venture.
Corelight spots $25m series B
UC Berkeley cybersecurity spinout Corelight has added General Catalyst to earlier investors including Accel Partners to bring its total funding to $34.2m.
OncoResponse answers questions with $40m series B
Helsinn Investment Fund and Alexandria Venture Investments both invested as MD Anderson-backed OncoResponse looks to advance five immuno-oncology drug candidates.
BridgeSat rockets into $10m series B
Allied Minds has backed a series B round for its portfolio company BridgeSat, which also welcomed Boeing HorizonX Ventures as an investor.

Other News

Utec helps Locix structure funding
Logistics data analytics platform Locix has emerged from stealth with $20m in funding provided by investors including University of Tokyo Edge Capital.
4D Molecular forces its way to $90m
Berkeley Catalyst Fund has helped close a $90m series B round for 4D Molecular Therapeutics, which emerged out of UC Berkeley.
Evox voices $45.4m series B
Oxford Sciences Innovation has contributed to a series B round for Evox Therapeutics, a spinout of University of Oxford that has also added GV as a shareholder.
Genomics detects $32.5m series B
Vertex Pharmaceuticals has led a series B round for Genomics, a spinout from University of Oxford that also attracted Oxford Sciences Innovation and IP Group.
Therachon takes $60m in series B funding
Therachon has welcomed back Inserm Transfert Initiative for its series B round, led by Novo.
Artios absorbs $84m series B
Existing shareholder IP Group has returned to back an $84m series B round for Artios, which also attracted corporates Pfizer, Novartis, AbbVie and Merck Group.

Editor's Picks

Coursera races ahead
In light of Coursera's $43m series B last week, news editor Gregg Bayes-Brown examines why the online course platform is rushing to grab the global student market.
Canvas paints $9m picture
Canvas Network, an online education platform developed by learning management software (LMS) provider Instructure which received $9.1m investment for the platform, has begun offering free and open online courses.
WRF finds its Resolve
In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Imperial helps PsiOxus raise $34m
UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.
test reg


Not yet subscribed?

See your subscription offers here